1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Krezel, A.M.
Krane, J.
Dennis, M.S.
Lazarus, R.A.
Wagner, G.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
US
Science
SCIEAS
0038
0036-8075
253
445
448
1862345
Solution structure of kistrin, a potent platelet aggregation inhibitor and GP IIb-IIIa antagonist.
1991
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
x-ray
1
1.0
7341.361
KISTRIN
1
man
polymer
rhodostomin
no
no
GKECDCSSPENPCCDAATCKLRPGAQCGEGLCCEQCKFSRAGKICRIPRGDMPDDRCTGQSADCPRYH
GKECDCSSPENPCCDAATCKLRPGAQCGEGLCCEQCKFSRAGKICRIPRGDMPDDRCTGQSADCPRYH
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Malayan pit viper
Calloselasma
Escherichia
sample
RHOD
8717
Calloselasma rhodostoma
562
Escherichia coli
plasmid
pzkis
repository
Initial release
Version format compliance
Version format compliance
Database references
1
0
2003-01-28
1
1
2008-04-28
1
2
2011-07-13
1
3
2012-09-05
2003-01-28
SPRSDE
RCSB
Y
RCSB
2002-11-02
REL
REL
target function
18
18
2D NOESY
2D NOESY
5 mM
4.7
ambient
298
K
torsion angle dynamics
1
closest to the average
2mM kistrin
95% H2O/5% D2O
Bruker
processing
XWINNMR
1.1
MSI
processing
FELIX
1995
refinement
OPAL
600
Bruker
AMX
750
Varian
INOVA
GLY
1
n
1
GLY
1
A
LYS
2
n
2
LYS
2
A
GLU
3
n
3
GLU
3
A
CYS
4
n
4
CYS
4
A
ASP
5
n
5
ASP
5
A
CYS
6
n
6
CYS
6
A
SER
7
n
7
SER
7
A
SER
8
n
8
SER
8
A
PRO
9
n
9
PRO
9
A
GLU
10
n
10
GLU
10
A
ASN
11
n
11
ASN
11
A
PRO
12
n
12
PRO
12
A
CYS
13
n
13
CYS
13
A
CYS
14
n
14
CYS
14
A
ASP
15
n
15
ASP
15
A
ALA
16
n
16
ALA
16
A
ALA
17
n
17
ALA
17
A
THR
18
n
18
THR
18
A
CYS
19
n
19
CYS
19
A
LYS
20
n
20
LYS
20
A
LEU
21
n
21
LEU
21
A
ARG
22
n
22
ARG
22
A
PRO
23
n
23
PRO
23
A
GLY
24
n
24
GLY
24
A
ALA
25
n
25
ALA
25
A
GLN
26
n
26
GLN
26
A
CYS
27
n
27
CYS
27
A
GLY
28
n
28
GLY
28
A
GLU
29
n
29
GLU
29
A
GLY
30
n
30
GLY
30
A
LEU
31
n
31
LEU
31
A
CYS
32
n
32
CYS
32
A
CYS
33
n
33
CYS
33
A
GLU
34
n
34
GLU
34
A
GLN
35
n
35
GLN
35
A
CYS
36
n
36
CYS
36
A
LYS
37
n
37
LYS
37
A
PHE
38
n
38
PHE
38
A
SER
39
n
39
SER
39
A
ARG
40
n
40
ARG
40
A
ALA
41
n
41
ALA
41
A
GLY
42
n
42
GLY
42
A
LYS
43
n
43
LYS
43
A
ILE
44
n
44
ILE
44
A
CYS
45
n
45
CYS
45
A
ARG
46
n
46
ARG
46
A
ILE
47
n
47
ILE
47
A
PRO
48
n
48
PRO
48
A
ARG
49
n
49
ARG
49
A
GLY
50
n
50
GLY
50
A
ASP
51
n
51
ASP
51
A
MET
52
n
52
MET
52
A
PRO
53
n
53
PRO
53
A
ASP
54
n
54
ASP
54
A
ASP
55
n
55
ASP
55
A
ARG
56
n
56
ARG
56
A
CYS
57
n
57
CYS
57
A
THR
58
n
58
THR
58
A
GLY
59
n
59
GLY
59
A
GLN
60
n
60
GLN
60
A
SER
61
n
61
SER
61
A
ALA
62
n
62
ALA
62
A
ASP
63
n
63
ASP
63
A
CYS
64
n
64
CYS
64
A
PRO
65
n
65
PRO
65
A
ARG
66
n
66
ARG
66
A
TYR
67
n
67
TYR
67
A
HIS
68
n
68
HIS
68
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
GLU
34
A
N
GLU
34
A
O
LYS
37
A
O
LYS
37
A
N
ARG
46
A
N
ARG
46
A
O
ASP
55
A
O
ASP
55
1
A
A
TYR
HIS
67
68
-126.97
2
A
A
ARG
PRO
22
23
-144.98
4
A
A
GLN
SER
60
61
-145.19
5
A
A
ARG
PRO
22
23
-145.26
11
A
A
GLY
ASP
50
51
-149.32
16
A
A
ARG
PRO
22
23
-146.50
1
A
ARG
46
0.098
SIDE CHAIN
2
A
ARG
22
0.084
SIDE CHAIN
3
A
ARG
46
0.109
SIDE CHAIN
4
A
ARG
46
0.127
SIDE CHAIN
5
A
ARG
22
0.083
SIDE CHAIN
5
A
ARG
46
0.098
SIDE CHAIN
6
A
ARG
46
0.087
SIDE CHAIN
8
A
ARG
46
0.094
SIDE CHAIN
9
A
ARG
40
0.124
SIDE CHAIN
9
A
ARG
46
0.108
SIDE CHAIN
10
A
ARG
46
0.086
SIDE CHAIN
11
A
ARG
46
0.106
SIDE CHAIN
12
A
ARG
40
0.091
SIDE CHAIN
12
A
ARG
46
0.094
SIDE CHAIN
14
A
ARG
46
0.089
SIDE CHAIN
15
A
ARG
46
0.116
SIDE CHAIN
16
A
ARG
22
0.078
SIDE CHAIN
17
A
ARG
46
0.102
SIDE CHAIN
18
A
ARG
46
0.085
SIDE CHAIN
1
A
GLN
60
-140.60
23.49
1
A
PRO
65
-75.06
-77.88
1
A
ARG
66
-155.05
-55.12
1
A
TYR
67
-151.49
4.69
2
A
PRO
65
-74.96
-70.66
2
A
ARG
66
-172.74
-50.64
3
A
ARG
49
-147.42
30.01
3
A
PRO
65
-74.94
-80.24
3
A
ARG
66
-161.68
-55.86
4
A
ARG
49
-146.54
27.42
4
A
GLN
60
-163.27
-53.26
4
A
ARG
66
-169.75
-52.91
5
A
ASP
51
-140.21
28.66
5
A
PRO
65
-75.05
-74.43
5
A
ARG
66
-170.65
-49.83
6
A
PRO
65
-75.04
-70.12
6
A
ARG
66
-168.82
-54.35
7
A
LYS
2
58.87
-155.66
7
A
ARG
49
-146.43
28.79
7
A
PRO
65
-75.01
-83.09
7
A
ARG
66
-155.47
-53.96
8
A
ASP
51
-144.15
28.46
8
A
GLN
60
-174.51
-46.44
8
A
PRO
65
-74.93
-76.96
8
A
ARG
66
-168.91
-47.21
9
A
PRO
23
-75.03
-168.42
9
A
PRO
65
-74.94
-81.24
9
A
ARG
66
-168.11
-63.97
9
A
TYR
67
-151.79
8.79
10
A
PRO
65
-74.95
-82.38
10
A
ARG
66
-171.27
-52.91
11
A
PRO
65
-74.98
-80.09
11
A
ARG
66
-162.02
-57.68
12
A
GLN
60
-166.33
-45.76
12
A
ARG
66
-168.66
-57.23
13
A
PRO
65
-74.97
-82.03
13
A
ARG
66
-162.51
-59.31
13
A
TYR
67
-158.03
10.53
14
A
GLN
60
-142.42
26.66
14
A
ARG
66
-170.64
-55.24
15
A
GLN
60
-169.25
-49.62
15
A
PRO
65
-74.88
-76.58
15
A
ARG
66
-165.16
-60.43
16
A
PRO
23
-74.95
-168.83
16
A
ASP
51
-140.44
26.18
16
A
GLN
60
-166.79
-49.51
16
A
PRO
65
-75.05
-79.03
16
A
ARG
66
-163.12
-50.93
17
A
PRO
65
-74.92
-73.58
17
A
ARG
66
-169.41
-53.41
18
A
PRO
65
-74.86
-76.67
18
A
ARG
66
-165.36
-49.61
rhodostomin
REFINED STRUCTURE OF KISTRIN
1
N
N
disulf
2.082
A
CYS
4
A
SG
CYS
4
1_555
A
CYS
19
A
SG
CYS
19
1_555
disulf
1.995
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
14
A
SG
CYS
14
1_555
disulf
1.991
A
CYS
13
A
SG
CYS
13
1_555
A
CYS
36
A
SG
CYS
36
1_555
disulf
2.054
A
CYS
27
A
SG
CYS
27
1_555
A
CYS
33
A
SG
CYS
33
1_555
disulf
2.086
A
CYS
32
A
SG
CYS
32
1_555
A
CYS
57
A
SG
CYS
57
1_555
disulf
2.014
A
CYS
45
A
SG
CYS
45
1_555
A
CYS
64
A
SG
CYS
64
1_555
BLOOD CLOTTING
beta, venom, blood coagulation, rgd, Blood clotting
DISR_AGKRH
UNP
1
408
P30403
GKECDCSSPENPCCDAATCKLRPGAQCGEGLCCEQCKFSRAGKICRIPRGDMPDDRCTGQSADCPRYH
408
475
1N4Y
1
68
P30403
A
1
1
68
2
2
anti-parallel
anti-parallel
A
CYS
33
A
CYS
33
A
GLU
34
A
GLU
34
A
LYS
37
A
LYS
37
A
PHE
38
A
PHE
38
A
ILE
44
A
ILE
44
A
ARG
46
A
ARG
46
A
ASP
55
A
ASP
55
A
ARG
56
A
ARG
56